Underutilization of curative treatment among patients with non small cell lung cancer: Experience from a tertiary care centre in India

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 6, 2014, Pages 2875-2878

  Malik, Prabhat Singh ^a   Malik, Anita ^a   Deo, Suryanarayana Venkata ^a   Mohan, Anant ^b   Mohanti, Bidhu Kalyan ^a   Raina, Vinod ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Curative intent treatment; India; Non small cell lung cancer; Treatment utilization

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; CANCER STAGING; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLINICAL PRACTICE; FEMALE; FOLLOW UP; HUMAN; INDIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATIENT COMPLIANCE; PROGNOSIS; SURVIVAL RATE; TERTIARY CARE CENTER; UTILIZATION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; SURVIVAL RATE; TERTIARY CARE CENTERS;

EID: 84899832471     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.6.2875     Document Type: Article

References (16)

1. Crino L, Weder W, van Meerbeeck J, et al (2010). Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 103-15.
2. Cykert S, Dilworth-Anderson P, Monroe MH, et al (2010). Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA, 303, 2368-76.
3. Delaney G, Barton M, Jacob S, Jalaludin B (2003). A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol. 4, 120-8.
4. Delaney G, Jacob S, Featherstone C, Barton, M (2005). The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer, 104, 1129-37.
5. Erridge SC, Murray B, Price A, et al (2008). Improved treatment and survival for lung cancer patients in South-East Scotland. J Thorac Oncol, 3, 491-8.
6. Ettinger DS (2012). NCCN Clinical Practice Guidelines in Oncology for Non Small Cell Lung Cancer, Ver 2.2012.
7. Esnaola NF, Gebregziabher M, Knott K, et al (2008). Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg, 86, 220-6.
8. Fry WA, Phillips JL, Menck HR (1999). Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer, 86, 1867-76.
9. Mahmud SM, Reilly M, Comber H (2003). Patterns of initial management of lung cancer in the Republic of Ireland: a population-based observational study. Lung Cancer, 41, 57-64.
10. Parkin DM (2008). FJ, GLOBOCAN Cancer Incidence and Mortality Worldwide.
11. Peters S, Adjei AA, Gridelli C, et al (2012). Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 23, 56-64.
12. Stevens W, Stevens G, Kolbe J, Cox B (2007). Lung cancer in New Zealand: patterns of secondary care and implications for survival. J Thorac Oncol, 2, 481-93.
13. Tyldesley S, Boyd C, Schulze K, Walker H, Mackillop WJ (2001). Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys, 49, 973-85.
14. Ustaalioglu BBO, Unal OU, Turan U, et al (2103) Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences. Asian Pac J Cancer Prev, 14, 6287-92
15. Vinod SK, O'Connell DL, Simonella L, et al (2008). Gaps in optimal care for lung cancer. J Thorac Oncol, 3, 871-9.
16. Vinod SK, Sidhom MA, Gabriel GS, Lee MT, Delaney GP (2010). Why do some lung cancer patients receive no anticancer treatment? J Thorac Oncol, 5, 1025-32.